CBD Life Sciences Inc.

CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes

CBD Life Sciences Inc. (OTC:CBDL) announced the launch of its new CBD Flavored Vapes, which are nicotine-free and available in four flavors: Menthol, Berry, Tropical, and Mint. The CBD Vapes market is projected to grow from US$ 5.8 billion in 2026 to US$ 20.9 billion by 2033, with a CAGR of 20.5%. CEO Lisa Nelson stated that CBD vapes are emerging as a promising product opportunity in the CBD supplement industry, positioning CBDL to capture first-mover advantage and expand market share.

•5mo ago

CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free

CBD Life Sciences Inc. announced the launch of its new CBD Pouches, a nicotine-free, chew-style product designed for stress relief and relaxation. The pouches contain 250 MGs of Broad Spectrum CBD and are available in six flavors, including Winter Green, Maple Bourbon, and Mixed Berry. Management views the launch as a strategic move to capture first-mover advantage in an emerging category of the CBD supplement market.

•5mo ago

CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned

CBD Life Sciences executed a stock purchase agreement with FBC Holding to acquire 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel. Both entities are now wholly owned subsidiaries, a move the company states will streamline operations and consolidate its diverse brand portfolio to maximize shareholder value.

•6mo ago